Influenza A virus H5N8 hemagglutinin (HA (H5N8))

Influenza A virus H5N8 hemagglutinin is a viral envelope glycoprotein and a class I fusion protein found on the surface of the H5N8 influenza A virus. It forms a homotrimeric structure, with each monomer subdivided into a globular head domain (responsible for binding to sialic acid-containing receptors on host cells) and a stem domain (mediating fusion of the viral envelope with the host cell membrane)[1][2][5][7]. The protein is the principal antigen that determines host specificity and range, is essential for viral infectivity, and is the main target for neutralizing antibodies and vaccines[1][5][7]. Variations in HA, such as changes to glycosylation sites and the cleavage site, influence the pathogenicity, transmissibility, and antigenicity of the virus[2][7][9]. In highly pathogenic strains, a polybasic cleavage site enables activation by ubiquitous host proteases, which contributes to systemic infection and virulence[7][9]. H5N8 hemagglutinin plays a key role in zoonotic outbreaks and is the main focus of surveillance and control efforts against avian influenza in both animals and humans[4][6]. If any further subdivisions (e.g., specific sequence variants or clade information) are required, these can be derived from viral sequence databases or surveillance reports, but the above details reflect the generic properties of the H5N8 HA as recognized in virology and immunology.

Other names

H5N8 hemagglutininHA H5N8Influenza H5N8 HA proteinAvian influenza H5N8 hemagglutinin

Antibodies: Block sialic acid receptor binding, neutralizing viral entry[9]. Experimental fusion inhibitors: Block conformational change or membrane fusion. Vaccines: Stimulate antibody production against HA, preventing infection[1][9].